Hepatic Safety of Ketamine and Esketamine for Treatment-Resistant Depression: A Real-World Cohort Study.

Singh B, Leung JG, Pazdernik VK, Kung S, Vande Voort JL

Open source

DOI
10.1097/jcp.0000000000002228
Published
2026 Jul 28
Container
Journal of clinical psychopharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/jcp.0000000000002228,
  title = {Hepatic Safety of Ketamine and Esketamine for Treatment-Resistant Depression: A Real-World Cohort Study.},
  author = {Singh B and Leung JG and Pazdernik VK and Kung S and Vande Voort JL},
  year = {2026},
  journal = {Journal of clinical psychopharmacology},
  doi = {10.1097/jcp.0000000000002228},
  url = {https://doi.org/10.1097/jcp.0000000000002228}
}

RIS

TY  - JOUR
TI  - Hepatic Safety of Ketamine and Esketamine for Treatment-Resistant Depression: A Real-World Cohort Study.
AU  - Singh B
AU  - Leung JG
AU  - Pazdernik VK
AU  - Kung S
AU  - Vande Voort JL
PY  - 2026
JO  - Journal of clinical psychopharmacology
DO  - 10.1097/jcp.0000000000002228
UR  - https://doi.org/10.1097/jcp.0000000000002228
ER  - 

APA

B, S., JG, L., VK, P., S, K., & JL, V. V. (2026). Hepatic Safety of Ketamine and Esketamine for Treatment-Resistant Depression: A Real-World Cohort Study.. Journal of clinical psychopharmacology. https://doi.org/10.1097/jcp.0000000000002228

Source records